trial

Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)

NCTId NCT00281320
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 3 · Completed
Enrollment 122 (actual)
Sponsored by Organon and Co
Primary completion 2008-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 3
Status
Completed
Enrollment
122 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2006-02
Primary completion
2008-12
Eligibility
ALL · 65 Years

Interventions & indications

Drugs
Asenapine

Sponsors

Organon and CoLead Sponsor

Sites

0 total

Linked catalysts

1
Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717) — primary completion2008-12

Facts & assertions

4 sourced
Enrollment
122
Phase
PHASE3
Primary Completion Date
2008-12
Status
COMPLETED
relationships
The graph out of here
drug
Asenapine
drug
lead_sponsor
Organon and Co
company
indication
Psychosis
indication
Psychotic Disorders
indication